Early pulmonary immune hyporesponsiveness is associated with mortality after burn and smoke inhalation injury

Journal of Burn Care and Research

Volumn 33, Issue 1, 2012, Pages 26-35

  Davis, Christopher S ^a   Albright, Joslyn M ^a   Carter, Stewart R ^a   Ramirez, Luis ^a   Kim, Hajwa ^b   Gamelli, Richard L ^a   Kovacs, Elizabeth J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LEUKOCYTE; LUNG BURN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; BURNS; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNE TOLERANCE; INJURY SEVERITY SCORE; INTERLEUKINS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; SMOKE INHALATION INJURY; SURVIVAL RATE; TIME FACTORS;

EID: 84855785947     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e318234d903     Document Type: Article

References (49)

1. Pruitt BA, Wolf SE, Mason AD. Epidemiological, demographic, and outcome characteristics of burn injury. In: Herndon DN, editor. Total burn care. 3rd ed. Philadelphia: Elsevier; 2007. p. 14-32.
2. Miller SF, Bessey P, Lentz CW, Jeng JC, Schurr M, Browning S; ABA NBR Committee. National burn repository 2007 report: a synopsis of the 2007 call for data. J Burn Care Res 2008;29:862-70; discussion 871.
3. Schröder O, Laun RA, Held B, Ekkernkamp A, Schulte KM. Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock 2004;21: 306-10.
4. Schroeder O, Schulte KM, Schroeder J, Ekkernkamp A, Laun RA. The -1082 interleukin-10 polymorphism is associated with acute respiratory failure after major trauma: a prospective cohort study. Surgery 2008;143:233-42.
5. Huebinger RM, Rivera-Chavez F, Chang LY, et al. IL-10 polymorphism associated with decreased risk for mortality after burn injury. J Surg Res 2010;164:e141-5.
6. Gu W, Zeng L, Zhou J, et al. Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Med 2010;36:1261-5.
7. McDaniel DO, Hamilton J, Brock M, et al. Molecular analysis of inflammatory markers in trauma patients at risk of postinjury complications. J Trauma 2007;63:147-57; discussion 157-8.
8. Ami K, Kinoshita M, Yamauchi A, et al. IFN-gamma production from liver mononuclear cells of mice in burn injury as well as in postburn bacterial infection models and the therapeutic effect of IL-18. J Immunol 2002;169:4437-42. (Pubitemid 35178219)
9. Göebel A, Kavanagh E, Lyons A, et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg 2000; 231:253-61. (Pubitemid 30078809)
10. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996;120:290-6. (Pubitemid 26287816)
11. Lyons A, Goebel A, Mannick JA, Lederer JA. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg 1999;134:1317-23; discussion 1324.
12. O'Riordain MG, O'Riordain DS, Molloy RG, Mannick JA, Rodrick ML. Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury. J Surg Res 1996;64:95-101. (Pubitemid 26268735)
13. Gamelli RL, He LK, Liu H. Recombinant human granulocyte colony-stimulating factor treatment improves macrophage suppression of granulocyte and macrophage growth after burn and burn wound infection. J Trauma 1995;39: 1141-6; discussion 1146-7.
14. Molloy RG, Holzheimer R, Nestor M, Collins K, Mannick JA, Rodrick ML. Granulocyte-macrophage colonystimulating factor modulates immune function and improves survival after experimental thermal injury. Br J Surg 1995;82: 770-6.
15. Laffon M, Pittet JF, Modelska K, Matthay MA, Young DM. Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 1999;160(5 Pt 1): 1443-9.
16. Sakurai H, Soejima K, Schmalstieg FC, Nozaki M, Traber DL. Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep. Surg Today 2009;39:399-406.
17. Polk HC Jr, Cheadle WG, Livingston DH, et al. A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992;163:191-6. (Pubitemid 23059255)
18. Dries DJ. Interferon gamma in trauma-related infections. Intensive Care Med 1996;22(suppl 4):S462-7. (Pubitemid 26370897)
19. Wasserman D, Ioannovich JD, Hinzmann RD, Deichsel G, Steinmann GG. Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group. Crit Care Med 1998;26:434-9. (Pubitemid 28141475)
20. Park KH, Lee KH, Kim H, Hwang SO. The anti-inflammatory effects of ulinastatin in trauma patients with hemorrhagic shock. J Korean Med Sci 2010;25:128-34.
21. Greenhalgh DG, Saffle JR, Holmes JHt, et al. American BurnAssociation consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776-90. (Pubitemid 350085032)
22. Wahl WL, Ahrns KS, Brandt MM, Rowe SA, Hemmila MR, Arbabi S. Bronchoalveolar lavage in diagnosis of ventilatorassociated pneumonia in patients with burns. J Burn Care Rehabil 2005;26:57-61. (Pubitemid 40105196)
23. Endorf FW, Gamelli RL. Inhalation injury, pulmonary perturbations, and fluid resuscitation. J Burn Care Res 2007;28: 80-3. (Pubitemid 46087861)
24. Bird MD, Zahs A, Deburghgraeve C, Ramirez L, Choudhry MA, Kovacs EJ. Decreased pulmonary inflammation following ethanol and burn injury in mice deficient in TLR4 but not TLR2 signaling. Alcohol Clin Exp Res 2010;34:1733-41.
25. Baux S. Contributionà l'Etude du traitement local des brûlures thermiques étendues. Paris: These; 1961.
26. Herndon DN, Curreri PW, Abston S, Rutan TC, Barrow RE. Treatment of Burns. Curr Probl Surg 1987;24:341-97. (Pubitemid 17113290)
27. Shirani KZ, Pruitt BA Jr, Mason AD Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987;205:82-7. (Pubitemid 17225029)
28. Herndon DN, Barrow RE, Traber DL, Rutan TC, Rutan RL, Abston S. Extravascular lung water changes following smoke inhalation and massive burn injury. Surgery 1987;102: 341-9. (Pubitemid 17158336)
29. Abdi S, Herndon D, McGuire J, Traber L, Traber DL. Time course of alterations in lung lymph and bronchial blood flows after inhalation injury. J Burn Care Rehabil 1990;11:510-5.
30. Soejima K, Schmalstieg FC, Sakurai H, Traber L, Traber DL. Pathophysiological analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 2001;280:L1233-41.
31. Lange M, Hamahata A, Traber DL, et al. A murine model of sepsis following smoke inhalation injury. Biochem Biophys Res Commun 2010;391:1555-60.
32. Mizutani A, Enkhbaatar P, Esechie A, et al. Pulmonary changes in a mouse model of combined burn and smoke inhalation-induced injury. J Appl Physiol 2008;105:678-84.
33. Westphal M, Cox RA, Traber LD, et al. Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstricion. Crit Care Med 2006;34:1428-36.
34. Dai NT, Chen TM, Cheng TY, et al. The comparison of early fluid therapy in extensive flame burns between inhalation and noninhalation injuries. Burns 1998;24:671-5.
35. Navar PD, Saffle JR, Warden GD. Effect of inhalation injury on fluid resuscitation requirements after thermal injury. Am J Surg 1985;150:716-20. (Pubitemid 16213311)
36. Wright MJ, Murphy JT. Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin. J Trauma 2005;59:64-70. (Pubitemid 41271639)
37. Kurzius-Spencer M, Foster K, Littau S, et al. Tracheobronchial markers of lung injury in smoke inhalation victims. J Burn Care Res 2008;29:311-8. (Pubitemid 351498825)
38. Riyami BMS, Tree R, Kinsella J, et al. Changes in alveolar macrophage, monocyte, and neutrophil cell profiles after smoke inhalation injury. J Clin Pathol 1990;43:43-5. (Pubitemid 20063712)
39. Albright JA, Davis CS, Bird MD, et al. Elevated pulmonary inflammatory response in patients sustaining greater severity of smoke inhalation injury. Cytokine 2010;52:54.
40. Colohan SM. Predicting prognosis in thermal burns with associated inhalational injury: a systematic review of prognostic factors in adult burn victims. J Burn Care Res 2010;31: 529-39.
41. Krob MJ, D'Amico FJ, Ross DL. Do trauma scores accurately predict outcomes for patients with burns? J Burn Care Rehabil 1991;12:560-3.
42. Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the baux score. J Trauma 2010;68:690-7.
43. Hassan Z, Wong JK, Bush J, Bayat A, Dunn KW. Assessing the severity of inhalation injuries in adults. Burns 2010;36: 212-6.
44. Klein MB, Hayden D, Elson C, et al. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg 2007;245:622-8. (Pubitemid 46555667)
45. Rodriguez JL, Miller CG, Garner WL, et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-94; discussion 694-5.
46. Sakurai H, Soejima K, Schmalstieg FC, Nozaki M, Traber DL. Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep. Surg Today 2009;39:399-406.
47. Mokart D, Capo C, Blache JL, et al. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002;89:1450-6.
48. Dries DJ, Perry JF Jr. Interferon-gamma: titration of inflammation. Crit Care Med 2002;30:1663-4.
49. Nakos G, Malamou-Mitsi VD, Lachana A, et al. Immunoparalysis in patients with severe trauma and the effect of inhaledinterferon-gamma. Crit Care Med 2002;30:1488-94. (Pubitemid 34756229)